Vimarsana
Biggest News Aggregation in the World

Recursion Class News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Recursion Class. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Recursion Class Today - Breaking & Trending Today

Recursion Provides Business Updates and Reports First Quarter 2023 Financial Results - Vimarsana News

Recursion Provides Business Updates and Reports First Quarter 2023 Financial Results

Published: May 8, 2023

Entered into agreements to acquire Cyclica and Valence to bolster digital chemistry and generative AI capabilities in order to further create new chemical composition of matter for novel biological... | May 8, 2023

Source: marketscreener.com
Related Topics:
United StatesSalt Lake CityChris GibsonRecursion Pharmaceuticals IncDevelopment ExpensesProgram GenerationCerebral Cavernous MalformationTarget GammaRecursion ClassCavernous MalformationAdenomatous PolyposisProficient Ovarian CancerIndustrialized Program GenerationShareholder MeetingRecursion Annual Shareholder MeetingProxy StatementAdministrative ExpensesSan Francisco BayConsolidated StatementsConsolidated Balance SheetsRecursion PharmaceuticalsNc Stock ExchangePress ReleaseOvel Rxrx Us75629v1044
American biotech Recursion acquires two Canadian AI drug-discovery companies, Cyclica and Valence - Vimarsana News

American biotech Recursion acquires two Canadian AI drug-discovery companies, Cyclica and Valence

Published: May 8, 2023

An American biotech company is acquiring two Canadian startups in the artificial intelligence (AI) drug discovery space: Cyclica and Valence.

Source: betakit.com
Related Topics:
United StatesSalt Lake CityBenjamin BergenChris GibsonDaniel CohenYoshua BengioMelinda Gates FoundationInnovation Economy CouncilUniversity Of TorontoCouncil Of Canadian InnovatorsValence DiscoveryPerturba TherapeuticsInnovation EconomyCanadian InnovatorsRecursion Class